1. Hoffman, JI, Kaplan, S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39: 1890–1900.
2. Goh, YI, Bollano, E, Einarson, TR, Koren, G. Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. J Obstet Gynaecol Can 2006; 28: 680–689.
3. Botto, LD, Mulinare, J. Occurrence of congenital heart defects in relation to maternal mulitivitamin use. Am J Epidemiol 2000; 151: 878–884.
4. Jenkins, KJ, Correa, A, Feinstein, JA, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007; 115: 2995–3014.
5. Boot, MJ, Steegers-Theunissen, RP, Poelmann, RE, van Iperen, L, Gittenberger-de Groot, AC. Cardiac outflow tract malformations in chick embryos exposed to homocysteine. Cardiovasc Res 2004; 64: 365–373.
6. Li, D, Pickell, L, Liu, Y, Wu, Q, Cohn, JS, Rozen, R. Maternal methylenetetrahydrofolate reductase deficiency and low dietary folate lead to adverse reproductive outcomes and congenital heart defects in mice. Am J Clin Nutr 2005; 82: 188–195.
7. Frosst, P, Blom, HJ, Milos, R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111–113.
8. Hol, FA, van der Put, NM, Geurds, MP, et al. Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate-dehydrogenase, methenyltetrahydrofolatecyclohydrolase, formyltetrahydrofolate synthetase) in patients with neural tube defects. Clin Genet 1998; 53: 119–125.
9. Christensen, KE, Patel, H, Kuzmanov, U, Mejia, NR, Mackenzie, RE. Disruption of the mthfd1 gene reveals a monofunctional 10-formyltetrahydrofolate synthetase in mammalian mitochondria. J Biol Chem 2005; 280: 7597–7602.
10. Parle-McDermott, A, Kirke, PN, Mills, JL, et al. Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population. Eur J Hum Genet 2006; 14: 768–772.
11. Shi, M, Caprau, D, Romitti, P, Christensen, K, Murray, JC. Genotype frequencies and linkage disequilibrium in the CEPH human diversity panel for variants in folate pathway genes MTHFR, MTHFD, MTRR, RFC1 and GCP2. Birth Defects Res A Clin Mol Teratol 2003; 67: 545–549.
12. Vizcaino, G, Diez-Ewald, M, Herrmann, FH, Schuster, G, Torres-Guerra, E, Arteaga-Vizcaino, M. Homocysteinemia and its relationship with the methylentetrahydrofolate reductase polymorphism in various ethnic groups from western Venezuela. Invest Clin 2005; 46: 347–355.
13. Weisberg, IS, Jacques, PF, Selhub, J, et al. The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 2001; 156: 409–415.
14. Rady, PL, Szucs, S, Grady, J, et al. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, 1793G>A. Am J Med Genet 2002; 107: 162–168.
15. van Beynum, IM, den Heijer, M, Blom, HJ, Kapusta, L. The MTHFR 677C->T polymorphism and the risk of congenital heart defects: a literature review and meta-analysis. QJM 2007; 100: 743–753.
16. Hobbs, CA, Cleves, MA, Melnyk, S, Zhao, W, James, SJ. Congenital heart defects and abnormal maternal biomarkers of methionine and homocysteine metabolism. Am J Clin Nutr 2005; 81: 147–153.
17. Storti, S, Vittorini, S, Lascone, MR, et al. Association between 5,10-methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and conotruncal heart defects. Clin Chem Lab Med 2003; 41: 276–280.
18. McBride, KL, Fernbach, S, Menesses, A, et al. A family-based association study of congenital left-sided heart malformations and 5, 10-methylenetetrahydrofolate reductase. Birth Defects Res A Clin Mol Teratol 2004; 70: 825–830.
19. Nurk, E, Tell, GS, Refsum, H, Ueland, PM, Vollset, SE. Associations between maternal methylenetetrahydrofolate reductase polymorphisms and adverse outcomes of pregnancy: the Hordaland Homocysteine study. Am J Med 2004; 117: 26–31.
20. van Driel, LM, Verkleij-Hagoort, AC, de Jonge, R, et al. Two MTHFR polymorphisms, maternal B-vitamin intake, and CHDs. Birth Defects Res A Clin Mol Teratol 2008; 82: 474–481.
21. Brody, LC, Conley, M, Cox, C, et al. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am J Hum Genet 2002; 71: 1207–1215.
22. Cheng, J, Zhu, WL, Dao, JJ, Li, SQ, Li, Y. Relationship between polymorphism of methylenetetrahydrofolate dehydrogenase and congenital heart defect. Biomed Environ Sci 2005; 18: 58–64.
23. Wang, L, Ke, Q, Chen, W, et al. Polymorphisms of MTHFD, plasma homocysteine levels, and risk of gastric cancer in a high-risk Chinese population. Clin Cancer Res 2007; 13: 2526–2532.
24. Shen, H, Newmann, AS, Hu, Z, et al. Methylenetetrahydrofolate reductase polymorphisms/haplotypes and risk of gastric cancer: a case-control analysis in China. Oncol Rep 2005; 13: 355–360.
25. Shaw, GM, Iovannisci, DM, Yang, W, et al. Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes. Am J Genet A 2005; 138: 21–26.
26. van, B, Kapusta, L, Den, H, et al. Maternal MTHFR 677C>T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. Eur Heart J 2006; 27: 981–987.
27. Pereira, AC, Xavier-Neto, J, Mesquita, SM, Mota, GFA, Lopes, AA, Krieger, JE. Lack of evidence of association between MTHFR 677C>T polymorphism and congenital heart disease in a TDT study design. Int J Cardiol 2005; 105: 15–18.
28. Verkleij-Haqoort, A, Bliek, J, Sayed-Tabatabaei, F, Ursem, N, Steeqers, E, Steegers-Theunissen, R. Hyperhomocysteinemia and MTHFR polymorphisms in association with orofacial clefts and congenital heart defects: a meta-analysis. Am Med Genet A 2007; 143: 952–960.